GATTI, MILO
GATTI, MILO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma
2026 Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?
2026 Gatti, Milo; Bonazzetti, Cecilia; Secci, Benedetta; Giorgi, Beatrice; Rinaldi, Matteo; Cojutti, Pier Giorgio; Ambretti, Simone; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients
2026 Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis
2026 Gatti, Milo; De Paola, Riccardo; Giorgi, Beatrice; Pea, Federico
Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions
2026 Gatti, Milo; Pea, Federico
Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?
2026 Gatti, Milo; Pea, Federico
Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations
2026 Gatti, Milo; Pea, Federico
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion
2026 Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico
When and How to Use Subcutaneous Antibiotics
2026 Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development
2025 Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?
2025 Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F.
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections
2025 Bonazzetti, Cecilia; Rocchi, Ettore; Toschi, Alice; Derus, Nicolas Riccardo; Sala, Claudia; Pascale, Renato; Rinaldi, Matteo; Campoli, Caterina; Pasquini, Zeno Adrien Igor; Tazza, Beatrice; Amicucci, Armando; Gatti, Milo; Ambretti, Simone; Viale, Pierluigi; Castellani, Gastone; Giannella, Maddalena
Avoiding resistance development to newer drugs: open research lines
2025 Rinaldi, M.; Gatti, M.; Giannella, M.
Barriers and solutions for the European prescribing exam: a qualitative world café study
2025 Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E. J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J.
Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients
2025 Caselli, D.; Arico, M.; Castagnola, E.; Gatti, M.
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow
2025 Gatti, Milo; Pea, Federico
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement
2025 Cortegiani, Andrea; De Pascale, Gennaro; De Angelis, Giulia; Falcone, Marco; Ferrini, Arianna; Forniti, Arianna; Gatti, Milo; Girardis, Massimo; Grasselli, Giacomo; Pea, Federico; Rinaldi, Matteo; Sanguinetti, Maurizio; Viale, Pierluigi; Giarratano, Antonino
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes
2025 Rinaldi, Matteo; Rancan, Ilaria; Malerba, Federica; Gatti, Milo; Ancillotti, Leonardo; Tazza, Beatrice; Campoli, Caterina; Bonazzetti, Cecilia; Profiti, Beatrice; Caroccia, Natascia; Ambretti, Simone; Tumbarello, Mario; Viale, Pierluigi; Giannella, Maddalena
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis
2025 Babich, Stella; Cojutti, Pier Giorgio; Gatti, Milo; Pea, Federico; Di Bella, Stefano; Monticelli, Jacopo
Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae
2025 Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico